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Abstract
Objectives: The aim of this study was to assess the
prevalence of alcohol dependence and anxiety and
depressive disorder symptomatology among heroin users
in drug treatment. 
Method: Fifty-five clients on methadone maintenance
treatment programmes in Dublin were interviewed. 
Results: Prevalence rates were found to be 56% [n = 31]
for alcohol dependence, 56% [n = 31] for anxiety disorder
symptomatology, and 42% [n = 23] for depressive disorder
symptomatology. This finding of comorbid alcohol
dependence and psychopathology among methadone
maintenance treatment clients suggests that both clients’
health and methadone maintenance treatment participation
and completion rates may be compromised. 
Conclusions: Alcohol dependence and psychopathology
among methadone maintenance treatment clients should
be considered when providing effectively targeted services
to the drug using population. 
Keywords: Opiate dependence; alcohol dependence;
anxiety; depression; methadone.
Introduction
The Celtic Tiger phenomenon in Ireland was accompanied,
among the general population, by an increase of 41% in alco-
hol consumption per capita between 1989 and 1999.1 Also
in Ireland 27% of males and 21% of females consume in
excess of the recommended weekly limits of alcohol of 21
units for males and 14 units for females2 even though alco-
holism is known to result in social, psychosocial, legal,
economic and medical problems.3
Consumption in excess of the recommended weekly limits
is highest among males aged 18-34 and among semi-skilled
and unskilled individuals. International research data indicates
that alcohol misuse is also widely prevalent among drug
users.4 Alcohol consumption may be higher among
methadone users than non-users of the same age in the
general population5 and approximately 50% of methadone
maintenance treatment programme clients may be alco-
holics.6 It is also worth remembering that illicit drug users do
not generally confine their drug use to one primary drug.7
Darke and Zador7 proposed that the majority of heroin-
related deaths are not due to heroin overdose but rather that
to the synergistic effect of multiple drug use, including central
nervous system depressants such as alcohol. While the use
of a number of drugs including cocaine and amphetamines
may have negative consequences when taken concurrently
with heroin, studies have focused in particular on the misuse
of central nervous system depressants such as alcohol
among heroin users in drug treatment.8-10
Polydrug use among heroin users is a serious problem
both in relation to health outcomes and to the design of effec-
tive drug treatment programmes.4,8-10 Research on polydrug
use among methadone maintenance treatment clients in
Ireland indicates significant levels of multiple drug use. Urin-
analysis results from five Eastern Regional Health Authority
(ERHA) Addiction Centres show an aggregate clinic total of
65% positive for benzodiazepines, 30% positive for opiates
and 14% positive for tricyclics11 and these findings may point
to increasing polydrug misuse. 
Psychopathology also frequently co-exists with drug
dependence among opiate misusers entering treatment,12
there is some evidence of higher levels of comorbidity among
those on methadone programmes13 and research findings
indicate high rates of generalised anxiety disorder, depres-
sion, mood disorders and phobias among opiate users in
treatment.14,15 Alcohol dependent drug users in particular may
be at risk of developing psychiatric conditions.6 Alcohol use
by heroin users in methadone maintenance treatment can
lead to a reduction in positive response to treatment16 and
there may be a substitution effect between improvements in
illicit drug use and continued heavy drinking.4 Therefore
programmes aimed at reducing polydrug use, particularly
alcohol misuse, may need to be prioritised.
This study aimed to assess the prevalence of substance
use, particularly alcohol use, and mood state (specifically the
symptoms of anxiety and depression) among clients receiv-
ing methadone maintenance treatment for opiate misuse in
Ireland and expected to find polydrug use, high levels of alco-
hol use and symptoms of anxiety and depression.
Consequently brief, fully structured interviews took place with
clients in attendance at two methadone maintenance treat-
ment clinics in Dublin.  
Materials and methods 
Procedure
Ethical approval for the present study was received from
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the Ethics Committee, Trinity College, Dublin. The researcher
was part employed by the Psychology Department,
Drugs/AIDS Service, Cherry Orchard Hospital, Ballyfermot,
Dublin. Initially, 131 names (25% of the total number of
clients receiving daytime methadone maintenance treatment)
were randomly chosen by selecting every fourth name from
the list of clients attending the two methadone maintenance
treatment clinics. The researcher then approached all clients
whose names were on the revised list when they presented
for treatment. The study was outlined and clients were asked
if they would voluntarily participate in a brief, confidential
interview. Clients who were willing but unable to participate
when approached were approached again at a later date, to
a maximum of three times. 
Fully structured interviews (lasting approximately 20
minutes) between the researcher and the 55 methadone
maintenance treatment clients who agreed to participate took
place in the clinics. Interviews took place under the supervi-
sion of the senior clinical psychologist with the Drugs/AIDS
Service and the researcher received training in the imple-
mentation of the three instruments. Participants signed a
consent form which provided information on the research and
assured confidentiality and anonymity. 
The three instruments were employed in the order in which
they are described in the section on materials that follows. All
interviews took place between February 2002 and February
2003. Participants’ responses were subsequently encoded
and analysed. Clients were able to obtain feedback on their
interview from the senior clinical psychologist. 
Materials
Three instruments were administered verbally during the
brief, fully structured interviews: the Maudsley Addiction
Profile (MAP), the Alcohol Dependence Scale (ADS) and the
Hospital Anxiety and Depression Scale (HADS). 
The Maudsley Addiction Profile is a 60 item scale and
includes five subscales: 
1. General management information
2. Substance use
3. Health risk behaviour
4. Health symptoms
5. Personal/social functioning. 
The MAP refers to the 30 days prior to interview. The
MAP17 has good test-retest reliability (for example, retest reli-
ability coefficients for subscales three, four and five average
0.81). The MAP also has good factorial validity (correlations
between factors extracted from a range of scores do not
exceed 0.12 in absolute value, p > 0.05).
The Alcohol Dependence Scale is a 25 item scale and





• Severe dependence. 
The ADS refers to the 12 months prior to interview. The
ADS18 has good internal consistency reliability (Cronbach
alpha) at 0.92 and test-retest reliability at 0.92.19 It also has
good predictive validity.  
The Hospital Anxiety and Depression Scale20 is a 14 item
scale which is scored out of 21. It assesses levels of anxiety
and depression on four levels: normal (0-7), mild (8-10),
moderate (11-14), and severe (15-21). The HADS refers to
the week prior. Factor analyses of HADS indicate a two
factor solution in good accordance with the anxiety and
depression subscales, with correlations between the two
varying from 0.40-0.74 (mean of 0.56).21 Cronbach’s alpha
for the anxiety subscale are in the range of 0.68-0.93 (mean
0.83) and for the depression subscale of 0.67-0.90 (mean
0.82). Correlations between HADS and other often used
questionnaires range from 0.49-0.83.21
Results 
Statistical analysis
Scores on the MAP, ADS and HADS were encoded and
parametric and non-parametric statistical analyses were
performed. Continuous variables were collapsed into cate-
gorical variables where required, errors were screened,
normality was assessed, outliers were checked, and normal
distribution and homogeneity of variance were assessed
where necessary.  
The relationship between the anxiety and depression
subscales of the HADS was investigated using Pearson
product-moment correlation coefficient. Preliminary analyses
were performed to ensure no violation of the assumptions of
normality, linearity, and homoscedasticity. There was a posi-
tive correlation between the two variables [r = 0.73, n = 54,
p = 0.01], with high levels of anxiety associated with high
levels of depression. 
The relationship between number of substances used and
the presence of symptoms of anxiety (as measured on the
HAS) was investigated using Pearson product-moment
correlation coefficient. Preliminary analyses were performed
to ensure no violation of the assumptions of normality, linear-
ity and homoscedasticity. There was a medium, positive
correlation between the two variables [r = 0.34, n = 54, 
p < 0.05].
A one-way between-groups multivariate analysis of vari-
ance was also performed to investigate sex differences on
psychological well-being. Two dependent variables were
used: HAS scores and HDS scores. The independent vari-
able was gender. When the results for the dependent
variables were considered separately, the only difference to
reach statistical significance using a Bonferroni adjusted
alpha level of 0.025 was anxiety: F(1, 52) = 6.9, p = 0.011,
partial eta squared = 0.07. An inspection of the mean scores
indicated that females had higher HAS scores (mean =
11.57, SD = 5.03) than males (mean = 8, SD = 4.94).  
Participants
Participants were 55 out of 131 methadone maintenance
treatment clients approached by the researcher, giving a
response rate of 42%, in attendance at two South Western
Area Health Authority drug treatment clinics in Dublin. The
clinics were situated in Castle Street in Dublin city centre and
in the Aisling Clinic, Cherry Orchard Hospital, Ballyfermot.
The mean age of the sample was 29.3 years (SD 6.5, range
21-49) and 52.7% of participants were female. This created
a higher than usual female to male ratio as approximately
70% of clients in attendance for methadone maintenance
treatment in Dublin are male. The majority of participants
were unemployed (72.7%) and came from the clinics’ catch-
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ment areas, which are characterised by social and economic
disadvantage. 
Table 1 shows the results from the sample’s scores on the
ADS, HAS and HDS. It shows the prevalence among the
sample (expressed in percentages) of alcohol dependence
(56%: 95% CI 43%-69%), symptoms of clinical anxiety
(56%: 95% CI 43%-69%), and symptoms of clinical depres-
sion (42%: 95% CI 30%-55%). Prevalence rates are
expressed as level of severity: mild, moderate, and severe.  
Table 2 shows the results from the sample’s scores on the
MAP 2) substance use subscale. It shows the percentage of
the sample which used each of the drugs (percentages are
rounded upwards). Table 2 also shows the mean daily
amount consumed by users of each substance, as expressed
in the relative measure for each substance. Women
consumed on average approximately eight units (mean = 8.4,
SD = 4.7) of alcohol each day while men consumed on aver-
age approximately 13 units (mean = 12.7, SD = 6.7) of
alcohol each day.  
Discussion
The major finding of the present study was that of the 56%
of respondents who drank all showed some level of alcohol
dependence. Scores on the ADS indicate that all clients who
used alcohol (56.4%) were also to some extent dependent.
The mean daily amount of alcohol consumed (approximately
eight units for women and 13 units for men) also placed alco-
hol users in this sample well above the safer limits of weekly
alcohol consumption. The levels of alcohol dependence in
this study are similar to those found in other studies, such as
Gossop et al.4
The use of alcohol is socially condoned in Ireland and there
has been a large increase in the per capita consumption of
alcohol in Ireland in recent years.1 Nevertheless the findings
from the present study indicate particularly high levels of alco-
hol dependence among this methadone maintenance
treatment sample and may suggest a possible ‘substitution
effect’.4 Clients may be replacing one substance, heroin, for
another, alcohol. A significant minority (44%) in this study
consumed no alcohol. This high abstinence rate is also
greater than that expected in the general population, as found
in Gossop et al.4 While such an undertaking was outside the
scope of this study, an investigation of patterns of alcohol use
among methadone maintenance treatment clients may be
warranted so as to elucidate the reasons for such atypical
patterns of alcohol consumption. 
The second finding of this study was that over half (56.4%)
of methadone maintenance treatment clients presented with
the symptoms of clinical anxiety and a large minority (41.8%)
presented with the symptoms of clinical depression. While it
is worthwhile remembering that clinical populations tend to
present higher levels of psychopathology than general popu-
lations,22 these prevalence rates are much higher than those
expected among the general population. In Ireland approxi-
mately 5% of the general population have clinical depression
and this figure may rise to approximately 10% among those
in attendance in the GP surgery.23 While correlations of 0.6
between the anxiety and depression subscales of the HADS
are commonly reported in the literature,21 suggesting that this
instrument may not be measuring anxiety and depression
separately, the present study found that greater symptoms of
anxiety were associated with greater symptoms of depres-
sion. The demotivating and debilitating effects of psychiatric
conditions on methadone maintenance treatment participa-
tion in studies such as El Bassel et al6 is noteworthy. The
combined effect of substance use and psychiatric difficulties
may negatively impact on clients’ ability to make rational,
informed choices regarding methadone maintenance treat-
ment participation and substance use. 
The third finding of this study was that the number of
substances used by the sample ranged from one to six and
the majority (77%) used between one and three substances.
The majority of these were central nervous system depres-
sant users which suggests a serious risk of complications
due to multiple drug toxicity. There was also a large minority
(18%) using between four to six substances. This high level
of polydrug use, as suggested by other studies on
methadone maintenance treatment programmes in Ireland,11
poses a serious threat to the physiological and psychological
health of methadone maintenance treatment clients. 
Findings from this study indicate that the greater the
number of substances used by methadone maintenance
treatment clients the greater the prevalence of psychopatho-
logical symptomatology, specifically the symptoms of anxiety
disorder. Indeed the high prevalence rates of symptoms of
both anxiety and depressive disorders in the present study
may indicate a substantial psychologically dysfunctional
subgroup. 
A fourth finding of this study was the significant gender
differences in relation to the symptoms of psychopathology,
with females reporting significantly higher levels of symptoms
of anxiety. Nevertheless these differences in reported symp-
Severity Alcohol Anxiety (%) Depression (%)
dependence (%)
Mild 44 16 11
Moderate 11 18 22
Severe 2   22 9
Total 56 56 42 
Table 1: Prevalence of alcohol dependence, symptoms of clinical
anxiety, and symptoms of clinical depression among 55 clients on
methadone maintenance treatment
Drug Sample (%) Mean daily drug use
Cannabis 66 (n = 36) 3 joints
Alcohol 56 (n = 31) 6 units
Heroin 40 (n = 22) 0.4g
Illicit benzodiazepines 29 (n = 16) 5 pills
Illicit methadone 26 (n = 14) 0.06g
Amphetamines 0 0
Crack cocaine 0 0
Other 11 (n = 6) -ª
ª measures vary
Table 2: Prevalence and mean daily quantity of drug use
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toms of psychopathology could be assessed with caution as
they may indicate underreporting of psychological distress by
males. Also in relation to gender there was a larger than usual
response by females in this study (52.7%) whereas the
majority (approximately 70%) of clients receiving methadone
maintenance treatment in Dublin are male. 
This larger number of females may have influenced the esti-
mated prevalence of the symptoms of anxiety, as females can
yield higher scores on these scales. Also of note in relation
to sampling is that, while the response rate in the study was
42%, the similarities and/or differences between those
clients who refused to participate and those who took part
were not assessed leading to the possibility of sampling bias. 
This study found significant levels of alcohol dependence
and anxiety and depressive disorder symptomatology among
this methadone maintenance treatment sample. At the treat-
ment clinics in question clients receive multidisciplinary input
from nurses, social workers, pharmacists, psychiatrists and
clinical psychologists tasked with identifying and treating
addictions and psychiatric disorders. 
However the present study suggests that international
trends in polydrug use, alcohol use and in the prevalence of
mood disorders among methadone maintenance treatment
clients may also exist in the Irish context. Interventions aimed
at reducing alcohol use and psychopathology among
methadone maintenance treatment clients must be warranted
as well as increased screening for these disorders. 
In particular, further investigation of the relationship
between psychiatric symptoms and alcohol abuse is
warranted. Services could be created to meet the needs of
methadone maintenance treatment clients who present with
alcohol dependence and coexisting anxiety and depressive
disorders. 
To effectively address these difficulties protocols could be
introduced whereby all drug users presenting for methadone
maintenance treatment are automatically screened for alco-
hol use and dependence and psychopathology.
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